Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AHCO

AHCO - AdaptHealth Corp Stock Price, Fair Value and News

10.74USD+0.51 (+4.99%)Delayed as of 01 Mar 2024, 11:04 am ET
Watchlist

Market Summary

USD10.74+0.51
Delayedas of 01 Mar 2024, 11:04 am
4.99%

AHCO Alerts

  • Big fall in earnings (Y/Y)
  • Losses in recent quarter

AHCO Stock Price

View Fullscreen

AHCO RSI Chart

AHCO Valuation

Market Cap

1.4B

Price/Earnings (Trailing)

-2.01

Price/Sales (Trailing)

0.42

EV/EBITDA

-16.18

Price/Free Cashflow

9.49

AHCO Price/Sales (Trailing)

AHCO Profitability

EBT Margin

-22.62%

Return on Equity

-46.22%

Return on Assets

-15.04%

Free Cashflow Yield

10.53%

AHCO Fundamentals

AHCO Revenue

Revenue (TTM)

3.2B

Rev. Growth (Yr)

9.99%

Rev. Growth (Qtr)

6.74%

AHCO Earnings

Earnings (TTM)

-677.9M

Earnings Growth (Yr)

-7.3K%

Earnings Growth (Qtr)

43.73%

Breaking Down AHCO Revenue

52 Week Range

8.0316.39
(Low)(High)

Last 7 days

0.9%

Last 30 days

8.1%

Last 90 days

-12.2%

Trailing 12 Months

-63.7%

How does AHCO drawdown profile look like?

AHCO Financial Health

Current Ratio

1.21

Debt/Equity

1.45

Debt/Cashflow

0.23

AHCO Investor Care

Shares Dilution (1Y)

1.23%

Diluted EPS (TTM)

-5.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20233.0B3.1B3.1B3.2B
20222.7B2.8B2.9B3.0B
20211.3B1.7B2.1B2.5B
2020601.6M709.5M857.5M1.1B
2019391.4M437.5M483.6M529.6M
2018000345.3M

Tracking the Latest Insider Buys and Sells of AdaptHealth Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Feb 05, 2024
clemens jason a
acquired
-
-
139,112
chief financial officer
Feb 05, 2024
prast albert a.
acquired
-
-
71,339
chief technology officer
Feb 05, 2024
archbold christine e.
acquired
-
-
28,536
chief accounting officer
Feb 05, 2024
rietkerk shaw
acquired
-
-
71,339
chief operating officer
Feb 05, 2024
bush jonathan b
acquired
-
-
57,072
general counsel
Feb 05, 2024
parnes josh
acquired
-
-
231,853
president
Jan 02, 2024
barasch richard a
sold (taxes)
-66,980
7.26
-9,226
interim ceo
Dec 29, 2023
barasch richard a
acquired
-
-
22,291
interim ceo
Dec 12, 2023
peloton equity aerocare spv i, l.p.
sold
-
-
-2,220,280
-
Dec 12, 2023
lundberg theodore b.
sold
-
-
-211,449
-

1–10 of 50

Which funds bought or sold AHCO recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 28, 2024
AMERICAN INTERNATIONAL GROUP, INC.
reduced
-0.76
-96,651
374,866
-%
Feb 26, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
-45,000
181,000
-%
Feb 20, 2024
Quarry LP
reduced
-53.19
-29,479
17,686
-%
Feb 20, 2024
Covenant Partners, LLC
unchanged
-
-54,791
220,676
0.07%
Feb 16, 2024
GSA CAPITAL PARTNERS LLP
sold off
-100
-510,000
-
-%
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
11.42
-47,000
389,000
-%
Feb 16, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
added
53.52
2,222
9,222
-%
Feb 15, 2024
JANE STREET GROUP, LLC
reduced
-20.42
-1,307,660
2,299,890
-%
Feb 15, 2024
Farther Finance Advisors, LLC
new
-
3,339
3,339
-%
Feb 15, 2024
BARCLAYS PLC
added
250
694,000
1,076,000
-%

1–10 of 45

Are Funds Buying or Selling AHCO?

Are funds buying AHCO calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AHCO
No. of Funds

Unveiling AdaptHealth Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
6.75%
9,199,481
SC 13G/A
Feb 12, 2024
flynn james e
8.71%
13,674,318
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 08, 2024
blackrock inc.
10.3%
14,066,565
SC 13G/A
Aug 28, 2023
everest hill group inc.
7.14%
9,721,412
SC 13D/A
Aug 11, 2023
peloton equity aerocare spv i, l.p.
1.6%
2,220,277
SC 13D/A
May 16, 2023
peloton equity aerocare spv i, l.p.
3.3%
4,460,555
SC 13D/A
Feb 10, 2023
flynn james e
4.9%
7,693,292
SC 13G/A
Feb 09, 2023
vanguard group inc
6.09%
8,211,817
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G

Recent SEC filings of AdaptHealth Corp

View All Filings
Date Filed Form Type Document
Feb 27, 2024
10-K
Annual Report
Feb 27, 2024
8-K
Current Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report
Feb 07, 2024
4
Insider Trading
Feb 07, 2024
4
Insider Trading
Feb 07, 2024
4
Insider Trading
Feb 07, 2024
4
Insider Trading
Feb 07, 2024
4
Insider Trading

Peers (Alternatives to AdaptHealth Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
206.3B
40.1B
0.08% 5.41%
36.05
5.14
-8.12% -17.45%
68.0B
19.5B
1.90% -2.48%
54.16
3.49
4.02% -22.04%
22.7B
3.9B
13.67% -2.23%
51
5.88
3.42% 23.09%
20.7B
14.9B
3.05% 1.38%
7.81
1.39
2.01% 209.17%
MID-CAP
9.8B
12.3B
2.56% -12.12%
23.62
0.8
-2.44% -22.68%
9.6B
2.7B
6.89% -27.73%
-15
3.58
-4.68% 82.43%
9.3B
3.5B
8.76% 25.90%
32.61
2.66
4.97% 18.89%
6.8B
4.0B
-8.15% -6.44%
-50.38
1.71
1.10% 85.84%
3.5B
366.4M
-1.40% 20.18%
-569.18
9.46
33.86% 89.80%
2.4B
6.6B
-4.32% -4.67%
12.53
0.37
2.78% -0.99%
SMALL-CAP
1.4B
3.2B
8.08% -63.68%
-2.01
0.42
7.73% -1066.14%
355.5M
163.3M
8.18% -20.52%
-14.47
2.18
7.14% -56.09%
218.8M
329.5M
3.17% -52.24%
-15.5
0.66
0.49% 64.22%
72.8M
50.3M
4.50% -30.54%
-4.8
1.45
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.37
1.2
5.77% 8.23%

AdaptHealth Corp News

Latest updates
MarketBeat3 hours ago
Seeking Alpha27 Feb 202407:15 pm

AdaptHealth Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue6.7%858804793745780756728706702653617482348284232191150136124119-
Costs and Expenses-14.9%1,0761,265739718754704668655644578552467328271217183149128109114-
  S&GA Expenses4.6%47.0045.0050.0048.0037.0041.0043.0041.0035.0033.0043.0057.0032.0026.0017.0014.0025.0012.006.0013.0017.00
EBITDA Margin-388.9%-0.07*0.02*0.19*0.18*0.19*0.19*0.21*0.24*0.22*0.17*0.09*0.01*-0.08*-0.02*-------
Interest Expenses3.7%33.0032.0033.0032.0031.0029.0026.0025.0026.0024.0023.0022.0014.0012.007.008.008.0011.0015.006.00-
Income Taxes47.7%-18.10-34.605.00-1.715.006.009.006.0010.0012.0012.00-1.69-7.25-4.902.00-1.60-4.671.002.002.00-2.64
Earnings Before Taxes44.3%-271-48720.0015.003.0023.0024.0048.0033.0070.0092.00-5.34-97.73-66.9010.00-51.09-17.07-2.030.00-3.0320.00
EBT Margin-57.3%-0.23*-0.14*0.02*0.02*0.03*0.04*0.06*0.09*0.08*0.03*-0.04*-0.12*-0.20*-0.15*-------
Net Income43.7%-255-45415.0017.00-3.4416.0015.0042.0022.0058.0080.00-3.64-74.76-51.038.00-49.45-10.13-3.69-1.72-5.4522.00
Net Income Margin-55.3%-0.21*-0.14*0.01*0.01*0.02*0.03*0.05*0.08*0.06*0.03*-0.03*-0.09*-0.16*-0.12*-------
Free Cashflow206.3%67.0022.004.0051.00-45.9913.0026.00-10.7137.00-33.1685.00-17.2233.0022.00-------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets-4.6%4,5094,7255,2035,2835,2205,2385,2025,2045,2505,1924,6884,5201,8131,556742665547257256255369
  Current Assets10.9%6495855686475856326056156708235915043634842641951811.001.001.0091.00
    Cash Equivalents37.4%77.0056.0045.0010146.0011111911915033717813210027211148.0077.009.002.0015.0025.00
  Inventory-2.3%11411611513612812510310012310082.0075.0059.0046.0024.0018.0013.00---8.00
  Net PPE------47345542539934130929911010283.0087.0064.00---62.00
  Goodwill-10.4%2,7253,0413,5523,5453,54512.005.002.003,51310346.0040.0099954450.0074.0026744.0014.00--
Liabilities1.9%3,0422,9853,0163,1163,0623,0783,0643,0843,1843,1972,7942,7281,5331,2118147656124112109.00266
  Current Liabilities19.8%5374484585244564674354445005026065134223152571911543.002.001.00136
  Long Term Debt-100.0%-2,1272,1362,1692,1532,1622,1712,1802,1842,1871,7761,749777723443464395---127
    LT Debt, Current33.4%53.0040.0040.0040.0035.0030.0025.0020.0020.0020.0097.0018.008.008.003.003.002.00---7.00
    LT Debt, Non Current-1.5%2,0952,1272,1362,1692,1532,1622,1712,1802,1842,1871,7761,749777723443464395---127
Shareholder's Equity-15.3%1,4671,7322,1872,1672,1512,1602,1382,1212,0671,9941,8941,79228131517.0026.001.005.005.005.005.00
  Retained Earnings-63.9%-652-39856.0042.0026.0029.0013.00-1.27-43.02-65.96-124-203-199-118-70.34-74.81-40.262.002.003.00-13.37
  Additional Paid-In Capital0.2%2,1502,1452,1402,1352,1302,1262,1192,1132,1072,0572,0161,99455848517.0026.004.003.003.002.003.00
Shares Outstanding-1.7%13313513513413413413413413413212011152.00--------
Minority Interest12.7%8.007.006.008.007.006.004.005.005.004.004.004.00-74.04-45.83-42.59-46.35-26.96----
Float-------1,510---2,170---185---253--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations57.1%15599.0086.0014097.0010710366.0010127.0012918.0050.0034.0087.0024.0017.0017.0010.0016.0070.00
  Share Based Compensation14.7%5.005.007.006.006.006.006.006.004.005.007.009.008.006.003.002.005.000.000.005.00-
Cashflow From Investing-17.3%-90.42-77.10-100-89.57-145-95.34-89.93-80.10-266-186-158-1,213-188-509-6.00-111-22.47-23.69-12.53-26.18153
Cashflow From Financing-309.2%-43.86-10.72-42.404.00-15.59-19.75-14.16-16.55-21.7131875.001,228-34.10637-18.2058.0073.0013.00-9.98-0.37-202
  Buy Backs-20.00--9.00-11.003.00--------------

AHCO Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Net revenue$ 3,200,177$ 2,970,595$ 2,454,535
Revenue, Product and Service [Extensible Enumeration]Health Care, Patient Service [Member]Health Care, Patient Service [Member]Health Care, Patient Service [Member]
Grant income$ 0$ 0$ 10,595
Costs and expenses:   
Cost of net revenue$ 2,720,613$ 2,553,169$ 2,008,925
Cost, Product and Service [Extensible Enumeration]Health Care, Patient Service [Member]Health Care, Patient Service [Member]Health Care, Patient Service [Member]
General and administrative expenses$ 190,091$ 162,125$ 167,505
Depreciation and amortization, excluding patient equipment depreciation57,08764,89063,095
Goodwill impairment (note 5)830,78700
Total costs and expenses3,798,5782,780,1842,239,525
Operating (loss) income(598,401)190,411225,605
Interest expense, net130,299109,41495,195
Change in fair value of warrant liability (note 11)(34,482)(17,158)(53,181)
Change in fair value of contingent consideration common shares liability (note 11)00(29,389)
Loss on extinguishment of debt0020,189
Other loss, net29,5662531,832
(Loss) income before income taxes(723,784)97,902190,959
Income tax (benefit) expense(49,004)24,76932,806
Net (loss) income(674,780)73,133158,153
Income attributable to noncontrolling interest4,1153,8171,978
Net (loss) income attributable to AdaptHealth Corp.$ (678,895)$ 69,316$ 156,175
Weighted average common shares outstanding - basic (in shares)134,156134,175126,306
Weighted average common shares outstanding - diluted (in shares)134,418138,988133,034
Basic net income (loss) per share (note 12) (in dollars per share)$ (5.06)$ 0.47$ 1.12
Diluted net income (loss) per share (note 12) (in dollars per share)$ (5.31)$ 0.33$ 0.67

AHCO Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash$ 77,132$ 46,272
Accounts receivable388,910359,146
Inventory113,642127,754
Prepaid and other current assets69,33852,136
Total current assets649,022585,308
Equipment and other fixed assets, net495,101487,079
Operating lease right-of-use assets110,465129,506
Finance lease right-of-use assets31,9625,423
Goodwill2,724,9583,545,297
Identifiable intangible assets, net130,160162,773
Other assets21,12822,415
Deferred tax assets345,854281,786
Total Assets4,508,6505,219,587
Current liabilities:  
Accounts payable and accrued expenses391,994337,498
Current portion of long-term debt53,36835,000
Current portion of operating lease obligations29,27030,001
Current portion of finance lease obligations9,1222,211
Contract liabilities38,57031,641
Warrant liability4,0210
Other liabilities10,65419,863
Total current liabilities536,999456,214
Long-term debt, less current portion2,094,6142,153,267
Operating lease obligations, less current portion85,529104,394
Finance lease obligations, less current portion22,7463,950
Other long-term liabilities302,093305,501
Warrant liability038,503
Total Liabilities3,041,9813,061,829
Commitments and contingencies (Note 16)
Stockholders' Equity:  
Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized and 132,634,850 and 134,435,119 shares issued and outstanding as of December 31, 2023 and 2022, respectively1313
Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 shares issued and outstanding as of December 31, 2023 and 202211
Treasury stock, at cost (3,935,035 and 750,835 shares as of December 31, 2023 and 2022, respectively)(43,267)(13,992)
Additional paid-in capital2,149,9512,130,148
(Accumulated deficit) Retained earnings(652,600)26,295
Accumulated other comprehensive income4,3568,693
Total stockholders' equity attributable to AdaptHealth Corp.1,458,4542,151,158
Noncontrolling interest in subsidiary8,2156,600
Total Stockholders' Equity1,466,6692,157,758
Total Liabilities and Stockholders' Equity$ 4,508,650$ 5,219,587
AHCO
AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, including CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
 WEBSITEadapthealth.com
 EMPLOYEES10900

AdaptHealth Corp Frequently Asked Questions


What is the ticker symbol for AdaptHealth Corp? What does AHCO stand for in stocks?

AHCO is the stock ticker symbol of AdaptHealth Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of AdaptHealth Corp (AHCO)?

As of Thu Feb 29 2024, market cap of AdaptHealth Corp is 1.36 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers.

What is the fair value of AHCO stock?

You can check AHCO's fair value in chart for subscribers. The fair value of AdaptHealth Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of AdaptHealth Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AHCO so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is AdaptHealth Corp a good stock to buy?

The fair value guage provides a quick view whether AHCO is over valued or under valued. Whether AdaptHealth Corp is cheap or expensive depends on the assumptions which impact AdaptHealth Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AHCO.

What is AdaptHealth Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Feb 29 2024, AHCO's PE ratio (Price to Earnings) is -2.01 and Price to Sales (PS) ratio is 0.42. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AHCO PE ratio will change depending on the future growth rate expectations of investors.